Get startedLog in
    Picture of Lakewood-amedex Biotherapeutics logo

    LABT — Lakewood-amedex Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Lakewood-Amedex Biotherapeutics Announces Positive Data For The Advancement Of Lead Candidate, Nu-3

    Picture of Lakewood-amedex Biotherapeutics logoLakewood-amedex Biotherapeutics
    18/05/2026 14:20
    May 18 (Reuters) - Lakewood-amedex Biotherapeutics Inc LABT.O:

LAKEWOOD-AMEDEX BIOTHERAPEUTICS ANNOUNCES POSITIVE DATA FOR THE ADVANCEMENT OF LEAD CANDIDATE, NU-3, IN INFECTED DIABETIC FOOT ULCERS

LAKEWOOD-AMEDEX BIOTHERAPEUTICS : KEY FORMULATION, DELIVERY AND MANUFACTURING STEPS COMPLETED IN PREPARATION FOR PLANNED PHASE 2 CLINICAL TRIAL

Source text: ID:nPn2mNJZxa

Further company coverage: LABT.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lakewood-amedex Biotherapeutics

    See all news